ConductScience.org, home

Paper42005248

Highly Aggressive Relapsing Course of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease Requiring Intensive Care Unit Treatment and Quadruple Immunotherapy.

Sharma D and 3 others. Cureus, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Highly Aggressive Relapsing Course of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease Requiring Intensive Care Unit Treatment and Quadruple Immunotherapy. Papers, record 42005248. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42005248

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Highly Aggressive Relapsing Course of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease Requiring Intensive Care Unit Treatment and Quadruple Immunotherapy.
PubMed
Journal
Cureus
PubMed
Year
2026
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sharma DDeepak
2Böhmer WWiebke
3Kamm CPChristian P
4Diem LLara

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127402152A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association.Acta Neuropathol Commun2016https://conductscience.org/library/papers/27402152PubMed
237705970Comparison of live and fixed cell-based assay performance: implications for the diagnosis of MOGAD in a low-middle income country.Front Immunol2023https://conductscience.org/library/papers/37705970PubMed
336706773Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.Lancet Neurol2023https://conductscience.org/library/papers/36706773PubMed
439901660Real-world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell-based assay.Ann Clin Transl Neurol2025https://conductscience.org/library/papers/39901660PubMed
530728305A multicenter comparison of MOG-IgG cell-based assays.Neurology2019https://conductscience.org/library/papers/30728305PubMed
634785575Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders.Neurol Neuroimmunol Neuroinflamm2022https://conductscience.org/library/papers/34785575PubMed
732623596Cell-based assays for the detection of MOG antibodies: a comparative study.J Neurol2020https://conductscience.org/library/papers/32623596PubMed
840781064Reply to Letter: "Real-World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell-Based Assay".Ann Clin Transl Neurol2025https://conductscience.org/library/papers/40781064PubMed
929142145Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.J Neurol Neurosurg Psychiatry2018https://conductscience.org/library/papers/29142145PubMed
1039981240Successful sequential therapy with rituximab and telitacicept in refractory Anti-NMDA receptor encephalitis and MOG-associated demyelination: a case report and literature review.Front Immunol2025https://conductscience.org/library/papers/39981240PubMed
1134634625Meta-analysis of effectiveness of steroid-sparing attack prevention in MOG-IgG-associated disorder.Mult Scler Relat Disord2021https://conductscience.org/library/papers/34634625PubMed
1240460615MOGAD treatment outcomes and relapse characteristics: Real world experience from a Low-Middle income country.Mult Scler Relat Disord2025https://conductscience.org/library/papers/40460615PubMed
1340712508Relapse and disability outcomes in incident MOGAD patients undergoing watchful waiting after onset.Mult Scler Relat Disord2025https://conductscience.org/library/papers/40712508PubMed
1435785363Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.Front Neurol2022https://conductscience.org/library/papers/35785363PubMed
1540717732Interleukin-6 targeting antibodies for the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD): A review of current literature.AIMS Neurosci2025https://conductscience.org/library/papers/40717732PubMed
1632304439Novel insights into pathophysiology and therapeutic possibilities reveal further differences between AQP4-IgG- and MOG-IgG-associated diseases.Curr Opin Neurol2020https://conductscience.org/library/papers/32304439PubMed
1739778568Phenotype of Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in Children.J Clin Neurol2025https://conductscience.org/library/papers/39778568PubMed
1836905816Meta-analysis of the effectiveness of relapse prevention therapy for myelin-oligodendrocyte glycoprotein antibody-associated disease.Mult Scler Relat Disord2023https://conductscience.org/library/papers/36905816PubMed
1938314479Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.Mult Scler2024https://conductscience.org/library/papers/38314479PubMed
2031266527Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease.J Neuroinflammation2019https://conductscience.org/library/papers/31266527PubMed

See all 21 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MOG4340PubTator's text mininghttps://conductscience.org/library/genes/4340

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42005248

GET https://conductscience.org/api/papers/v1/42005248/references?page=2